Loading...
Universal Biosensors, Inc.
UBI.AX•ASX
Healthcare
Medical - Devices
A$0.02
A$-0.00(-16.67%)
Universal Biosensors, Inc. (UBI.AX) Financial Performance & Income Statement Overview
Explore the financials of Universal Biosensors, Inc. (UBI.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Revenue Growth
-5.28%
↓ 5.28%
Operating Income Growth
-1.73%
↓ 1.73%
Net Income Growth
-111.22%
↓ 111.22%
Operating Cash Flow Growth
15.86%
↑ 15.86%
Operating Margin
-279.92%
↓ 279.92%
Gross Margin
55.53%
↑ 55.53%
Net Profit Margin
-229.89%
↓ 229.89%
ROE
-76.86%
↓ 76.86%
ROIC
-103.24%
↓ 103.24%
Universal Biosensors, Inc. (UBI.AX) Income Statement & Financial Overview
Analyze Universal Biosensors, Inc.’s UBI.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.55M | $1.32M | $1.87M | $1.63M |
| Cost of Revenue | $711315.00 | $145563.00 | $1.27M | $700365.00 |
| Gross Profit | $843344.00 | $1.18M | $592287.00 | $925201.00 |
| Gross Profit Ratio | $0.54 | $0.89 | $0.32 | $0.57 |
| R&D Expenses | $795503.00 | $1.14M | $1.04M | $1.72M |
| SG&A Expenses | $4.34M | $4.69M | $3.58M | $3.72M |
| Operating Expenses | $5.31M | $5.99M | $4.62M | $5.44M |
| Total Costs & Expenses | $6.02M | $6.14M | $5.90M | $6.14M |
| Interest Income | $63391.00 | $101266.00 | $149952.00 | $126904.00 |
| Interest Expense | $24980.00 | $22103.00 | $6633.00 | $6660.00 |
| Depreciation & Amortization | $163210.00 | $163536.00 | $165181.00 | $255008.00 |
| EBITDA | -$3.67M | -$3.43M | -$3.24M | -$4.26M |
| EBITDA Ratio | -$2.36 | -$2.60 | -$1.73 | -$2.62 |
| Operating Income | -$4.47M | -$4.81M | -$4.03M | -$4.51M |
| Operating Income Ratio | -$2.87 | -$3.65 | -$2.16 | -$2.77 |
| Other Income/Expenses (Net) | $629826.00 | $1.22M | $601282.00 | $114292.00 |
| Income Before Tax | -$3.84M | -$4.66M | -$3.86M | -$4.37M |
| Income Before Tax Ratio | -$2.47 | -$3.52 | -$2.07 | -$2.69 |
| Income Tax Expense | $0.00 | -$1.06M | -$452219.00 | -$580026.00 |
| Net Income | -$3.84M | -$3.60M | -$3.41M | -$3.79M |
| Net Income Ratio | -$2.47 | -$2.72 | -$1.83 | -$2.33 |
| EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Weighted Avg Shares Outstanding | $298.07M | $298.07M | $298.07M | $270.96M |
| Weighted Avg Shares Outstanding (Diluted) | $298.07M | $298.07M | $298.07M | $270.96M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan